Sign in
Subscribe
News
Tech trail
Trade floor
Export
The killer50
Blogs
Awards
Directory
Events
A worldwide window to Cambridge business, innovation and technology
AstraZeneca to pay up to $2.4bn for Fusion Pharmaceuticals
Cambridge headquartered AstraZeneca has agreed to acquire Canadian and US company Fusion Pharmaceuticals to accelerate the development of nextgen radioconjugates (RCs) to treat cancer.
Mission raises £25.2m to progress clinical development of key drugs
Blue chip international investors have weighed into a £25.2 million fundraising round to back significant progress for Cambridge clinical stage biotech Mission Therapeutics. The company is developing first-in-class therapeutics that enhance mitophagy to promote cell/organ health.
AstraZeneca buying French company for $1.05bn to grow rare disease pipeline
A restless drive to discover new medicines for rare disease sufferers globally is prompting Cambridge Big Biotech AstraZeneca to pay $1.05 billion for French company Amolyt Pharma.
Safest and smartest ever motoring as Arm drives Autonomous Vehicle tech revolution
Cambridge superchip powerhouse Arm has lit the touchpaper to an historic uptick in Autonomous Vehicle technology – a move that will revolutionise motor manufacture beyond imagination.
Cambridge startup OutSee Ltd aims to unearth new drug targets with its AI genomics tech
No-one could accuse Cambridge scientist Dr Julian Gough of pursuing a ‘get rich quick’ philosophy as he continues to cross the bridge between academia and business.
Academia
Sharewatch
Manufacturing
World at their feet: New generation founders launch Cambridge University Accelerator in style
12 Mar 2024 - 12:00
Anglia Ruskin to invest £10m in Writtle College following strategic merger
11 Mar 2024 - 12:00
Form the Future levelling the playing field in UK’s ‘most unequal city’
10 Mar 2024 - 12:00
Business awards
Entries now being accepted
Business directory
Browse our listings of Cambridge companies
The killer 50
The 50 hottest disruptive technology companies
News
AstraZeneca to pay up to $2.4bn for Fusion Pharmaceuticals
Cambridge headquartered AstraZeneca has agreed to acquire Canadian and US company Fusion Pharmaceuticals to accelerate the development of nextgen radioconjugates (RCs) to treat cancer.
Somerset NHS deploys Lucida Medical AI to transform prostate cancer diagnosis
A groundbreaking way of supporting doctors to diagnose prostate cancer using the latest artificial intelligence capability has launched in Somerset deploying Cambridge technology.
bit.bio elevated to UK tech elite
Cambridge innovator bit.bio, which is coding human cells for novel cures, has been chosen to be part of Tech Nation’s Future Fifty initiative.
Record results speak volumes for Midwich
Global audio visual distributor Midwich plc has unveiled a record financial performance and market share gains for the year to December 31 and broke the £50 million adjusted pre-tax profits barrier for the first time in its history.
More news
Tech trail
Mission raises £25.2m to progress clinical development of key drugs
Blue chip international investors have weighed into a £25.2 million fundraising round to back significant progress for Cambridge clinical stage biotech Mission Therapeutics. The company is developing first-in-class therapeutics that enhance mitophagy to promote cell/organ health.
Cambridge startup OutSee Ltd aims to unearth new drug targets with its AI genomics tech
No-one could accuse Cambridge scientist Dr Julian Gough of pursuing a ‘get rich quick’ philosophy as he continues to cross the bridge between academia and business.
First funds for biomaterials innovator to advance aviation, automotive and other industries
A spin-out from the University of East Anglia has raised more than £250k in its maiden round to accelerate commercialisation of patented technology designed to enhance the water resistance of biomaterials.
Cambridge entrepreneur backed by Innovate UK to build the first worldwide learning web
Cambridge tech entrepreneur Piyush Ahuja has secured undisclosed funding from Innovate UK for building ‘a learning web’. Besides the Innovate UK funding, Piyush will also receive 12 months of tailored business support to help grow the venture. It is spearheaded by his company Cambridge Innovation Labs.
More Tech trail
Trade floor
AstraZeneca to pay up to $2.4bn for Fusion Pharmaceuticals
Cambridge headquartered AstraZeneca has agreed to acquire Canadian and US company Fusion Pharmaceuticals to accelerate the development of nextgen radioconjugates (RCs) to treat cancer.
AstraZeneca buying French company for $1.05bn to grow rare disease pipeline
A restless drive to discover new medicines for rare disease sufferers globally is prompting Cambridge Big Biotech AstraZeneca to pay $1.05 billion for French company Amolyt Pharma.
Cambridge to the fore in healthcare acquisition
A new force on the advisory block has played a key role in the acquisition by HealthComms group Helios of Cambridge-based Cogentia. Alfa Corporate Finance worked with Cogentia in its sale for an undisclosed sum to Helios Global Group.
Riverlane takes more quantum leaps both sides of the Atlantic
Riverlane, the Cambridge quantum computing innovator, is piling up the patents – notably in the US – and has teamed up with Rolls-Royce and Canadian company Xanadu for another exciting venture.
FRP the Manx cat’s whiskers with pounce for GWC
FRP Advisory Group plc, which has extensive East of England operations, has acquired Douglas-based GWC, which provides advisory and insolvency services across the Isle of Man.
More Trade floor